Institutional investors hold a majority ownership of VRX through the 92.23% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Pharmaceuticals: Other industry. Last, during the quarter ended December 2014, these large investors purchased a net $13.0 million shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
PERSHING SQUARE CAPITAL MANAGEME... Bought 19.5 Million shares of Valeant Pharmaceuticals